Stay updated on Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial
Sign up to get notified when there's something new on the Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial page.

Latest updates to the Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNo substantive changes detected in the study details between versions. Eligibility criteria, primary outcomes, and locations appear unchanged.SummaryDifference0.0%

- Check21 days agoChange DetectedPage revision label updated from v3.4.3 to v3.5.0. This update appears to reflect version history rather than changes to the study content.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded 'Amyloidosis' as a topic and introduced a Resources section listing the Genetic and Rare Diseases Information Center. There are no changes to core content or study details.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page shows a new Revision: v3.4.2. The deletions remove a government funding lapse notice and a prior Revision: v3.4.1, indicating updated site versioning and removal of the operating-status banner. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedAdded a government funding notice banner with operating status links (cc.nih.gov and opm.gov) and updated the page revision label from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial page.